Artiva (ARTV) Director Daniel G. Baker Receives Award of 13,750 Shares

What Happened
Daniel G. Baker, a director of Artiva Biotherapeutics (ARTV), received a grant/award of 13,750 derivative shares (reported as acquisition code "A") on September 8, 2026. The filing shows $0.00 per share and $0 total cash paid at grant — this is a compensation award/option rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-09-08; transaction type: Grant/Award (code A); instrument: derivative (option/award).
• Amount: 13,750 shares; reported price: $0.00 (no cash exchanged at grant).
• Vesting/other footnote: The shares subject to the option will vest in full on the earlier of September 8, 2027, or the date of the issuer's 2027 annual stockholder meeting (Footnote F1).
• Shares owned after transaction: Not specified in the provided summary of the filing.
• Filing timeliness: Reported on the same date (2026-09-08), indicating a timely filing.

Context
This is a director compensation award (derivative grant) that vests in the future and does not represent an immediate market purchase or sale. Such grants are commonly part of board compensation packages and do not, by themselves, indicate the insider's intent to buy or sell stock in the open market. For options/derivatives, note whether shares are later exercised or sold in subsequent filings for a fuller picture.